Figure S1 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells

Authors :: Roland Schüle
Jochen Maurer
Toufike Kanouni
Jeffrey A. Stafford
Michael B. Wallace
Jiangchun Xu
Elmar Stickeler
Melanie Boerries
Marie Follo
Amelie Proske
Peter Bronsert
Nicola Iovino
Fides Zenk
Anita Allen
Dominica Willmann
Sylvia Urban
Bogdan-Tiberius Preca
Juliane Strietz
Stella S. Stepputtis
Eric Metzger
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Characterization of the breast cancer stem cell line BCSC2 in vitro and in vivo. Like BCSC1 in Figure 1, BCSC2-derived xenografts also recapitulate the original patient tumor.

Full Text Access

Tools